Expression of DOG1, PDGFRA, and p16 in gastrointestinal stromal tumors

Gut and Liver

Volumn 5, Issue 2, 2011, Pages 171-180

  Jung, Sung Hee ^a   Suh, Kwang Sun ^b   Kang, Dae Young ^b   Kang, Dong Wook ^a   Kim, Young Beum ^b   Kim, Eun Sun ^b  

^a Eulji University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

DOG1; Gastrointestinal stromal tumor; Mutation; p16; Platelet derived growth factor alpha

Indexed keywords

DOG1 PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN P16; STEM CELL FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COLON TUMOR; CORRELATIONAL STUDY; ESOPHAGUS TUMOR; EXON; FEMALE; FOLLOW UP; GASTROINTESTINAL TUMOR; GENE MUTATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METASTASIS; MISSENSE MUTATION; PROGNOSIS; PROTEIN EXPRESSION; RADIOGRAPHY; SMALL INTESTINE TUMOR; SPINDLE CELL; STOMACH TUMOR; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 79959346638     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.2.171     Document Type: Article

References (30)

1. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580. (Pubitemid 28067289)
2. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-1269. (Pubitemid 28221878)
3. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol 2000;13:1134-1142.
4. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004;22:3813-3825. (Pubitemid 41095223)
5. Debiec-Rychter M, Wasag B, Stul M, et al. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. J Pathol 2004;202:430-438. (Pubitemid 38456161)
6. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708-710. (Pubitemid 36159485)
7. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459-465. (Pubitemid 34747864)
8. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004;165:107-113. (Pubitemid 38821818)
9. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008;32:210-218. (Pubitemid 351172135)
10. Schneider-Stock R, Boltze C, Lasota J, et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol 2003;21:1688-1697. (Pubitemid 46638579)
11. Steigen SE, Bjerkehagen B, Haugland HK, et al. Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway. Mod Pathol 2008;21:46-53.
12. Sabah M, Cummins R, Leader M, Kay E. Loss of heterozygosity of chromosome 9p and loss of p16INK4A expression are associated with malignant gastrointestinal stromal tumors. Mod Pathol 2004;17:1364-1371. (Pubitemid 39472991)
13. Schneider-Stock R, Boltze C, Lasota J, et al. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin Cancer Res 2005;11(2 Pt 1):638-645. (Pubitemid 40116890)
14. Schmieder M, Wolf S, Danner B, et al. p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome. Neoplasia 2008;10:1154-1162.
15. Choi SY, Suh KS, Kim YB, Lee HJ, Kim ES, Park MJ. KIT/PDGFRA expression and mutation in testicular seminoma and ovarian dysgerminoma. Korean J Pathol 2009;43:528-534.
16. Antonescu CR. Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas. Mod Pathol 2008;21 Suppl 2:S31-S36. (Pubitemid 351592776)
17. Zheng S, Chen LR, Wang HJ, Chen SZ. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Hepatogastroenterology 2007;54:2285-2290.
18. Miselli F, Millefanti C, Conca E, et al. PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors. Am J Surg Pathol 2008;32:738-743. (Pubitemid 351600827)
19. Liegl B, Hornick JL, Corless CL, Fletcher CD. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol 2009;33:437-446.
20. Katoh M, Katoh M. FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome 11q13, encodes the eighttransmembrane protein homologous to C12orf3, C11orf25 and FLJ34272 gene products. Int J Oncol 2003;22:1375-1381.
21. Haller F, Gunawan B, von Heydebreck A, et al. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clin Cancer Res 2005;11:6589-6597. (Pubitemid 41338999)
22. Agaram NP, Baren A, Arkun K, Dematteo RP, Besmer P, Antonescu CR. Comparative ultrastructural analysis and KIT/PDG-FRA genotype in 125 gastrointestinal stromal tumors. Ultrastruct Pathol 2006;30:443-452. (Pubitemid 46018572)
23. Braconi C, Bracci R, Bearzi I, et al. KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. Ann Oncol 2008;19:706-710. (Pubitemid 351461041)
24. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006;30:477-489. (Pubitemid 43740149)
25. Corless CL, Schroeder A, Griffith D, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 2005;23:5357-5364. (Pubitemid 46206989)
26. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29:52-68. (Pubitemid 40023952)
27. Lasota J, Dansonka-Mieszkowska A, Sobin LH, Miettinen M. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest 2004;84:874-883. (Pubitemid 38833247)
28. Wardelmann E, Hrychyk A, Merkelbach-Bruse S, et al. Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. J Mol Diagn 2004;6:197-204. (Pubitemid 39136646)
29. Chang HM, Ryu MH, Lee H, et al. PDGFRalpha gene mutation and protein expression in gastrointestinal stromal tumors. Oncology 2008;74:88-95. (Pubitemid 351915015)
30. Kang HJ, Nam SW, Kim H, et al. Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene 2005;24:1066-1074. (Pubitemid 40313883)